Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis

[1]  Zoe Stableford,et al.  British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). , 2006, Rheumatology.

[2]  M. Carroll,et al.  Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection. , 2008, Seminars in arthritis and rheumatism.

[3]  Jeffrey R Curtis,et al.  American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[4]  S. Bryan,et al.  Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. , 2008, Health technology assessment.

[5]  F. Buttgereit,et al.  Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial , 2008, The Lancet.

[6]  J. Fries,et al.  Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. , 2007, JAMA.

[7]  J. Giles,et al.  Rheumatoid arthritis and reproduction. , 2007, Rheumatic diseases clinics of North America.

[8]  R. Guarisco,et al.  Extrahepatic manifestations of chronic HCV infection. , 2007, Journal of gastrointestinal and liver diseases : JGLD.

[9]  D. Furst,et al.  Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient. , 2007, Rheumatic diseases clinics of North America.

[10]  H. Chng,et al.  Outcomes of chronic hepatitis B infection in Oriental patients with rheumatic diseases. , 2007, Annals of the Academy of Medicine, Singapore.

[11]  M. Boers,et al.  Effects of glucocorticoids on radiological progression in rheumatoid arthritis. , 2007, The Cochrane database of systematic reviews.

[12]  B Combe,et al.  EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.

[13]  Stanley B. Cohen,et al.  Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. , 2006, Arthritis and rheumatism.

[14]  R. Misra,et al.  Guidelines for tuberculosis prophylaxis during anti‐tumour necrosis factor‐α treatment: Indian Rheumatology Association , 2006 .

[15]  M. Galeazzi,et al.  Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients. , 2006, Autoimmunity reviews.

[16]  K. Jones,et al.  Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data , 2006, Arthritis research & therapy.

[17]  P. Emery,et al.  The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. , 2006, Arthritis and rheumatism.

[18]  B. Saltin,et al.  Evidence for prescribing exercise as therapy in chronic disease , 2006, Scandinavian journal of medicine & science in sports.

[19]  C. Doré,et al.  A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. , 2005, Rheumatology.

[20]  A. Kavanaugh,et al.  Rheumatic disease in the elderly: rheumatoid arthritis. , 2005, Clinics in geriatric medicine.

[21]  S. Dubey,et al.  Management of early rheumatoid arthritis. , 2005, Clinical medicine.

[22]  L. Laine,et al.  Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  M. Uffmann,et al.  Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score , 2005, Arthritis research & therapy.

[24]  Robert Riddell,et al.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.

[25]  Andreas Hoeft,et al.  Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. , 2005, The New England journal of medicine.

[26]  Marc A Pfeffer,et al.  Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention , 2005, The New England journal of medicine.

[27]  R. Misra,et al.  Open-label evaluation of the efficacy and safety of etanercept in rheumatoid arthritis , 2005 .

[28]  H. Schumacher,et al.  Dosing of antirheumatic drugs in renal disease and dialysis. , 2004, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[29]  P. Pillans,et al.  Leflunomide-Associated Pancytopenia With or Without Methotrexate , 2004, The Annals of pharmacotherapy.

[30]  P. Emery,et al.  Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. , 2004, The New England journal of medicine.

[31]  F. Cicuttini,et al.  How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? , 2004, Annals of the rheumatic diseases.

[32]  J. Brok,et al.  Glucocorticosteroids for viral hepatitis C. , 2001, The Cochrane database of systematic reviews.

[33]  Return Undeliverable.  Gastroduodenal Ulcers Associated with the Use of Non-steroidal Anti-inflammatory Drugs : A Systematic Review of Preventive Pharmacological Interventions , 2004 .

[34]  A. Malaviya,et al.  Prevalence of rheumatoid arthritis in the adult Indian population , 2004, Rheumatology International.

[35]  V. Strand,et al.  Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). , 2003, The Journal of rheumatology.

[36]  A. Olivé,et al.  Anti-TNF treatment in secondary amyloidosis. , 2003, Rheumatology.

[37]  M. Hochberg,et al.  Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[38]  G. Farrell,et al.  Hepatotoxicity associated with non-steroidal anti-inflammatory drugs. , 2003, Clinics in liver disease.

[39]  P. Tugwell,et al.  Transcutaneous electrical nerve stimulation (TENS) for the treatment of rheumatoid arthritis in the hand. , 2003, The Cochrane database of systematic reviews.

[40]  M. Suarez‐Almazor,et al.  Rheumatoid arthritis. , 2003, Clinical evidence.

[41]  A. Malaviya,et al.  Validation of an Indian version of the Health Assessment Questionnaire in patients with rheumatoid arthritis. , 2002, Rheumatology.

[42]  J. Geytenbeek.  Evidence for Effective Hydrotherapy , 2002 .

[43]  P. Tugwell,et al.  Therapeutic ultrasound for the treatment of rheumatoid arthritis. , 2002, The Cochrane database of systematic reviews.

[44]  J. Bijlsma,et al.  Analgesia and the Patient With Osteoarthritis , 2002, American journal of therapeutics.

[45]  E. Pathan,et al.  Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment , 2002, Annals of the rheumatic diseases.

[46]  G. Luxton,et al.  Effect of Hemodialysis on Leflunomide Plasma Concentrations , 2002, The Annals of pharmacotherapy.

[47]  P. Tugwell,et al.  Thermotherapy for treating rheumatoid arthritis. , 2002, The Cochrane database of systematic reviews.

[48]  A. Chopra,et al.  Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study. , 2001, The Journal of the Association of Physicians of India.

[49]  P. Lavin,et al.  Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis. , 2000, The Journal of rheumatology.

[50]  M. Dunn.  Are COX-2 selective inhibitors nephrotoxic? , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[51]  M. Yuen,et al.  Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. , 2000, Clinical and experimental rheumatology.

[52]  B. Brenner.  Brenner and Rector's The Kidney , 2000 .

[53]  Lise,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[54]  J. Kremer,et al.  A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. , 1999, The New England journal of medicine.

[55]  C. Bologna,et al.  Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients. , 1997, The Journal of rheumatology.

[56]  R. Madhok,et al.  Toleration, side-effects and efficacy of sulphasalazine in rheumatoid arthritis patients of different ages. , 1993, The Quarterly journal of medicine.

[57]  P. Åstrand.  Influence of Scandinavian scientists in exercise physiology , 1991 .

[58]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[59]  I. Björkhem,et al.  Prednisolone excretion in human milk. , 1985, The Journal of pediatrics.

[60]  D. Smith,et al.  Low dose adrenocorticosteroids in the management of elderly patients with rheumatoid arthritis: selected examples and summary of efficacy in the long-term treatment of 97 patients. , 1983, Seminars in arthritis and rheumatism.

[61]  H. Siemensen,et al.  Pharmacokinetics of azathioprine under haemodialysis. , 1976, International journal of clinical pharmacology and biopharmacy.